Northislet AB is a Swedish investment firm specializing in Life Science investments within the Nordic region. The firm takes significant ownership in small growth companies, applying an active strategy to enhance long-term value through active ownership. Northislet invests in various stages of a company's development, referred to as 'ISLETS,' and partners with exceptional entrepreneurs to drive innovation and growth.
Is Northislet AB the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Northislet AB, along with a list of other relevant VCs, is available on Hopohopo.io.
Stages
Pre-seed, Seed, Series A, Series B or later
First ticket size
SEK 7,020,000 - SEK 7,020,000
When approaching Northislet AB, emphasize how your company's innovations align with their focus on healthcare transformation and efficiency. Highlight your potential to provide tools or solutions that enhance productivity in the Pharma and Life Science sectors. Demonstrate a commitment to long-term growth and sustainability, as Northislet values enduring partnerships and responsible development. ([northislet.com](https://www.northislet.com/strategy?utm_source=openai))
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.